Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement In Brief

This article was originally published in The Gray Sheet

Executive Summary

CMS issues proposed decision memo for PET for solid tumors and sends letter to Smith & Nephew clarifying G codes for negative pressure wound therapies. More reimbursement news.

You may also be interested in...



CMS Proposal To Limit Number Of PET Scans For Cancer Patients Sparks Outcry

In nearly 200 public comments, professional societies, manufacturers and the National Oncologic PET Registry strongly opposed CMS’ proposal to cover only one positron emission tomography scan after a cancer patient has completed initial treatment.

CMS Proposal To Limit Number Of PET Scans For Cancer Patients Sparks Outcry

In nearly 200 public comments, professional societies, manufacturers and the National Oncologic PET Registry strongly opposed CMS’ proposal to cover only one positron emission tomography scan after a cancer patient has completed initial treatment.

Reimbursement In Brief

CMS posts its report to Congress on NCDs for FY 2011. MedCAC announces meeting on genetic cancer tests. DOJ and HHS announce record health care fraud recoveries in fiscal 2012. More reimbursement news.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031897

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel